Teva Pharmaceuticals USA Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per recall — FDA D-0776-2021
CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.